The patient has been in the critical care unit for 3 weeks and has been on the intra-aortic balloon pump for the past 3 days
The patient's condition has been serious, and hourly assessments and vital signs have been necessary. The nursing staff has noted that the patient has been unable to achieve sleep for more than 30 minutes at a time. The patient has been given diazepam (Valium) prn. Which techniques may assist in assessing the patient's sleep pattern?
a. Correlating sleep time with vital signs
b. Documenting sleep periods of more than 90 minutes
c. Assessing degree of arousal on hourly checks
d. Observing the length of NREM sleep periods
B
Keeping a sleep chart for 48 to 72 hours and documenting sleep periods greater than 90 minutes, the number and length of awakenings, and the total possible sleep time can help assess sleep patterns in the critical care unit.
You might also like to view...
Which of these statements about acute lymphocytic leukemia (ALL) is TRUE?
a. It occurs primarily in adolescence and after age 55. b. It is usually fatal, regardless of treatment. c. It occurs primarily in children under age 15. d. It can be cured with stem cell transplantation.
The perinatal nurse teaches the student nurse about the physiological changes in pregnancy that most often contribute to the increased incidence of urinary tract infections. These changes include:
Select all answers that apply: A) Relaxation of the smooth muscle of the urinary sphincter B) Relaxation of the smooth muscle of the bladder C) Inadequate emptying of the bladder D) Increased incidence of bacteriuria
The nurse asks a client, "Do you wear the clothes you wear at work to home?" This is an example of which subject on the exposure history?
A) Present work B) Past work C) Home/residence D) Concerns
Identify the antibiotics/families of antibiotics in which nephrotoxicity is a major concern.
A. Sulfonamides and third-generation cephalosporins B. Macrolides and fourth-generation cephalosporins C. Tetracyclines and second-generation cephalosporins D. Aminoglycosides and first-generation cephalosporins